Mr Francisco Brito e Abreu > Uría Menéndez – Proença Carvalho > Lisbon, Portugal > Lawyer Profile

Uría Menéndez – Proença Carvalho
EDIFICIO RODRIGO URIA
PRAÇA MARQUÊS DE POMBAL, 12
1250-162 LISBOA
Portugal
Francisco Brito e Abreu photo

Work Department

M&A, Private Equity, Healthcare and Life Sciences.

Position

Partner

Career

Francisco Brito e Abreu joined Uría Menéndez in 2001 after working as an in-house counsel in the Portuguese subsidiary of a multinational corporation, a privately owned holding company and a listed Portuguese company and as a lawyer in a prestigious Portuguese law firm. He was made partner of Uría Menéndez in January 2005.

He focuses his practice on commercial and corporate law issues and has extensive experience in corporate restructuring, M&A and private equity transactions.

Francisco also has vast experience in the pharmaceutical sector, focusing on regulatory, distribution and advertising matters.

Languages

English, Spanish and French.

Memberships

Portuguese Bar Association.

Education

Law Degree, Universidade Lusíada, Lisbon, 1991.

Lawyer Rankings

Portugal > Commercial, corporate and M&A

(Leading individuals)

Francisco Brito e Abreu  – Uría Menéndez – Proença Carvalho

The corporate and M&A team at Uría Menéndez – Proença Carvalho is praised for its ‘very good technical knowledge‘ and ‘great attention to detail.’ Esteemed as trusted advisers to private equity firms and corporates across all of Portugal’s major industries, the team is well placed to handle an array of corporate transactions. Key contact Francisco Brito e Abreu boasts considerable experience in corporate restructuring, M&A and private equity transactions, particularly excelling in the pharmaceutical sector, while Catarina Tavares Loureiro focuses on M&A transactions involving both private and listed companies. Joana Torres Ereio is routinely instructed by domestic and international corporates on M&A, private equity, venture capital deals and commercial agreements. Former practice head Duarte Garin retired in December 2023.